Seventeen clinical scenarios developed for which amyloid or tau PET may be considered. HealthDay News — Appropriate use criteria (AUC) for the use of amyloid and tau positron emission tomography (PET) ...

Please provide your email address to receive an email when new articles are posted on . The revised criteria offer guidance for clinicians to determine when amyloid and tau PET are recommended.

Roche (SIX: RO, ROG; OTCQX: RHHBY) today announced that the United States Food and Drug Administration (FDA) has cleared its ...

In May, the FDA cleared the first blood-based diagnostic test for Alzheimer's disease, the Lumipulse G pTau 217/β-Amyloid 1-42 Plasma Ratio, intended to be used in people 55 and older who have signs ...

In a mouse model of Alzheimer’s disease, lithium deficiency (right) dramatically increased amyloid beta deposits in the brain compared with mice that had normal physiological levels of lithium (left).

Can you escape your genetic inheritance, and do lifestyle changes actually make a difference? Daniel Cossins set out to ...

At this year’s Alzheimer’s Association International Conference, held July 27-31 in Toronto, scientists introduced a plethora of new assays for biomarkers that could improve diagnosis and tracking of ...

A research team from the Institut de Neurociències of the Universitat Autònoma de Barcelona (INc-UAB) has discovered that the two key pathological hallmarks of Alzheimer's-tau protein and beta-amyloid ...

Cannabidiol (CBD) can calm two critical immune pathways that drive neuroinflammation in Alzheimer's disease, according to a ...